{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-077358","form_type":"8-K","ticker":"AMRX","cik":"0001723128","company_name":"Amneal Pharmaceuticals, Inc.","filed_at":"2022-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.943612+00:00","generated_at":"2026-06-26T22:24:45.595326+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Amneal EVP & Chief Commercial Officer–Specialty Joseph Todisco to depart by May 15, 2022","bullets":["Joseph Todisco is stepping down from his role as EVP, Chief Commercial Officer – Specialty.","He will remain through a transition period expected to end May 15, 2022.","Todisco is leaving to pursue an opportunity outside the company."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-077358","json":"https://secwatch.observer/filing/0001193125-22-077358.json","markdown":"https://secwatch.observer/filing/0001193125-22-077358.md","text":"https://secwatch.observer/filing/0001193125-22-077358.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1723128/000119312522077358/0001193125-22-077358-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1723128/000119312522077358/d294673d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T22:24:45.595326+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8ff2b7dfaa","claim":"Joseph Todisco departed as Executive Vice President, Chief Commercial Officer – Specialty at Amneal Pharmaceuticals, Inc..","evidence_excerpt":"On March 15, 2022, Joseph Todisco, Executive Vice President, Chief Commercial Officer – Specialty for Amneal Pharmaceuticals, Inc. (the “Company”), informed the Company of his decision to step down from his role to pursue another opportunity outside of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1723128/000119312522077358/0001193125-22-077358-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Executive Vice President, Chief Commercial Officer – Specialty"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}